Loading cancer entity…
Loading cancer entity…
Clinical trials
636 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (99)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00100880 | Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01652768 | PRESENCE Project: An Early Palliative Care Intervention in Brain Tumors | terminated | N/A | 1 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT01697514 |
| A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma |
| withdrawn |
| Phase 1 |
| 0 |
| Eli Lilly and CompanyINDUSTRY |
| 1 |
| Aug 27, 2013 |
| clinicaltrials |
| NCT01205334 | Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme(COGLI) | terminated | Phase 1 / Phase 2 | 2 | Baylor College of MedicineOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00006461 | Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor | completed | Phase 3 | 82 | Children's Oncology GroupNETWORK | 1 | Aug 9, 2013 | clinicaltrials |
| NCT00012181 | Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00994500 | Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT01890278 | Phase II Trial of Conventional Versus IMRT Whole Brain Radiotherapy for Brain Metastases | unknown | N/A | 60 | Good Samaritan Hospital Medical Center, New YorkOTHER | 1 | Jul 1, 2013 | clinicaltrials |
| NCT00004078 | Irinotecan in Treating Children With Refractory Solid Tumors | completed | Phase 2 | 181 | Children's Oncology GroupNETWORK | 1 | Jun 14, 2013 | clinicaltrials |
| NCT00077454 | Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 95 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00101270 | Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT01076530 | Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 2 | May 3, 2013 | clinicaltrials |
| NCT00005811 | Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment | completed | Phase 2 | 77 | National Cancer Institute (NCI)NIH | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00053963 | FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00110032 | Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors | terminated | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00363272 | Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00352820 | Experience of Brain Tumor Caregivers | completed | — | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT01650922 | Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples | completed | — | 4 | Stanford UniversityOTHER | 1 | Jul 26, 2012 | clinicaltrials |
| NCT00970788 | A Pilot Study of Using Video Images in Advance Care Planning in Malignant Glioma Patients | completed | N/A | 50 | Massachusetts General HospitalOTHER | 1 | May 1, 2012 | clinicaltrials |
| NCT00241670 | Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid | completed | Phase 3 | 415 | medac GmbHINDUSTRY | 0 | Apr 26, 2012 | clinicaltrials |
| NCT00404495 | Combination of Irinotecan and Temozolomide in Children With Brain Tumors. | completed | Phase 2 | 83 | PfizerINDUSTRY | 8 | Apr 18, 2012 | clinicaltrials |
| NCT00460395 | Surgery Versus Stereotactic Radiosurgery in the Treatment of Single Brain Metastasis: A Randomized Trial | completed | Phase 3 | 64 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 24, 2012 | clinicaltrials |
| NCT00036569 | A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Feb 13, 2012 | clinicaltrials |
| NCT00504660 | 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients | completed | Phase 2 | 75 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 11, 2012 | clinicaltrials |
| NCT00600054 | Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma | completed | Phase 2 | 44 | YM BioSciencesINDUSTRY | 3 | Jul 6, 2011 | clinicaltrials |
| NCT00520936 | A Study of Pemetrexed in Children With Recurrent Cancer | completed | Phase 2 | 72 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00392119 | MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors | completed | Phase 1 | 18 | BioTex, Inc.INDUSTRY | 1 | Jan 1, 2010 | clinicaltrials |
| NCT00418327 | Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma | completed | Phase 1 | 48 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Aug 7, 2009 | clinicaltrials |
| NCT00599703 | Language Function in Patients With Brain Tumors | completed | — | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00185861 | Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma | completed | Phase 1 | 12 | Stanford UniversityOTHER | 1 | Apr 9, 2009 | clinicaltrials |
| NCT00553748 | Phase I, Open Label, Single Center Safety Study of [F-18]FLT | completed | Phase 1 | 11 | Siemens Molecular ImagingINDUSTRY | 1 | Jul 3, 2008 | clinicaltrials |
| NCT00001502 | A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00180791 | High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood | unknown | Phase 2 | 71 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 18, 2007 | clinicaltrials |
| NCT00505141 | Urban Environmental Exposures and Childhood Cancer | completed | — | — | Georgetown UniversityOTHER | 1 | Jul 23, 2007 | clinicaltrials |
| NCT00180947 | Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse | unknown | Phase 2 | 210 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00231712 | Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant | unknown | — | 50 | Julius-Maximilians UniversityOTHER | 1 | Aug 23, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Sep 30, 2013source: clinicaltrials